Avant-garde: an automated data-driven DIA data curation tool.


Journal

Nature methods
ISSN: 1548-7105
Titre abrégé: Nat Methods
Pays: United States
ID NLM: 101215604

Informations de publication

Date de publication:
12 2020
Historique:
received: 18 02 2019
accepted: 25 09 2020
pubmed: 18 11 2020
medline: 9 2 2021
entrez: 17 11 2020
Statut: ppublish

Résumé

Several challenges remain in data-independent acquisition (DIA) data analysis, such as to confidently identify peptides, define integration boundaries, remove interferences, and control false discovery rates. In practice, a visual inspection of the signals is still required, which is impractical with large datasets. We present Avant-garde as a tool to refine DIA (and parallel reaction monitoring) data. Avant-garde uses a novel data-driven scoring strategy: signals are refined by learning from the dataset itself, using all measurements in all samples to achieve the best optimization. We evaluate the performance of Avant-garde using benchmark DIA datasets and show that it can determine the quantitative suitability of a peptide peak, and reach the same levels of selectivity, accuracy, and reproducibility as manual validation. Avant-garde is complementary to existing DIA analysis engines and aims to establish a strong foundation for subsequent analysis of quantitative mass spectrometry data.

Identifiants

pubmed: 33199889
doi: 10.1038/s41592-020-00986-4
pii: 10.1038/s41592-020-00986-4
pmc: PMC7723322
mid: NIHMS1632766
doi:

Substances chimiques

Peptides 0
Proteome 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1237-1244

Subventions

Organisme : NCI NIH HHS
ID : U24 CA210986
Pays : United States
Organisme : NHGRI NIH HHS
ID : U54 HG008097
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA210979
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA214125
Pays : United States

Références

J Am Soc Mass Spectrom. 2016 Nov;27(11):1745-1751
pubmed: 27562500
Nat Methods. 2016 Sep;13(9):777-83
pubmed: 27479329
Nat Methods. 2017 Sep;14(9):903-908
pubmed: 28783153
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Mol Cell Proteomics. 2012 Jun;11(6):O111.016717
pubmed: 22261725
J Proteome Res. 2014 Dec 5;13(12):5415-30
pubmed: 25244318
Proteomics. 2003 Jun;3(6):847-50
pubmed: 12833507
Anal Chem. 2005 Apr 1;77(7):2187-200
pubmed: 15801753
Mol Cell Proteomics. 2020 Jun;19(6):944-959
pubmed: 32234965
Anal Chem. 2009 Aug 1;81(15):6481-8
pubmed: 19572557
Proteomics. 2015 Mar;15(5-6):964-80
pubmed: 25430050
Nat Methods. 2011 May;8(5):430-5
pubmed: 21423193
J Proteomics. 2016 Jan 30;132:51-62
pubmed: 26585461
Mol Cell Proteomics. 2016 May;15(5):1622-41
pubmed: 26912667
J Proteomics. 2015 Nov 3;129:108-120
pubmed: 26381204
Nat Biotechnol. 2014 Mar;32(3):219-23
pubmed: 24727770
Mass Spectrom Rev. 2014 Nov-Dec;33(6):452-70
pubmed: 24281846
Mol Cell Proteomics. 2010 Oct;9(10):2252-61
pubmed: 20610777
Nat Methods. 2015 Mar;12(3):258-64, 7 p following 264
pubmed: 25599550
Bioinformatics. 2014 Sep 1;30(17):2524-6
pubmed: 24794931
Nat Protoc. 2015 Jun;10(6):887-903
pubmed: 25996789
Nat Methods. 2017 Sep;14(9):921-927
pubmed: 28825704
Mol Cell Proteomics. 2015 May;14(5):1411-8
pubmed: 25713123
Mol Cell Proteomics. 2012 Aug;11(8):540-9
pubmed: 22535207
Nat Methods. 2018 May;15(5):371-378
pubmed: 29608554
Bioinformatics. 2010 Apr 1;26(7):966-8
pubmed: 20147306
Nat Biotechnol. 2016 Nov;34(11):1130-1136
pubmed: 27701404
Nat Commun. 2018 Dec 3;9(1):5128
pubmed: 30510204
Mol Cell Proteomics. 2006 Apr;5(4):589-607
pubmed: 16399765

Auteurs

Alvaro Sebastian Vaca Jacome (AS)

Broad Institute of MIT and Harvard, Cambridge, MA, USA. svaca@broadinstitute.org.

Ryan Peckner (R)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Cogen Therapeutics, Cambridge, MA, USA.

Nicholas Shulman (N)

University of Washington Genome Sciences, Seattle, WA, USA.

Karsten Krug (K)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Katherine C DeRuff (KC)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Adam Officer (A)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Karen E Christianson (KE)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Brendan MacLean (B)

University of Washington Genome Sciences, Seattle, WA, USA.

Michael J MacCoss (MJ)

University of Washington Genome Sciences, Seattle, WA, USA.

Steven A Carr (SA)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Jacob D Jaffe (JD)

Broad Institute of MIT and Harvard, Cambridge, MA, USA. jjaffe@inzentx.com.
Inzen Therapeutics, Cambridge, MA, USA. jjaffe@inzentx.com.
Inzen Therapeutics, Cambridge, MA, USA. jjaffe@inzentx.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH